Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture
暂无分享,去创建一个
W Noble | W. Noble | D. Hanger | C. Garwood | A. Pooler | C J Garwood | A M Pooler | J Atherton | D P Hanger | C. Garwood | J. Atherton | D. Hanger
[1] L. V. Van Eldik,et al. Apolipoprotein E Attenuates β‐Amyloid‐Induced Astrocyte Activation , 1998 .
[2] D. Jo,et al. Proapoptotic Effects of Tau Cleavage Product Generated by Caspase-3 , 2001, Neurobiology of Disease.
[3] W. Noble,et al. Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] L. V. Van Eldik,et al. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches. , 2007, International review of neurobiology.
[5] J. Cho,et al. Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. , 2004, The Journal of biological chemistry.
[6] Jialin C. Zheng,et al. Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders , 2009, Journal of neurochemistry.
[7] M. Hatten,et al. Neuronal regulation of astroglial morphology and proliferation in vitro , 1985, The Journal of cell biology.
[8] H. Arias,et al. The role of inflammation in Alzheimer's disease. , 2005, The international journal of biochemistry & cell biology.
[9] Roger N Gunn,et al. In-vivo measurement of activated microglia in dementia , 2001, The Lancet.
[10] M. Lynch,et al. The age‐related increase in IL‐1 type I receptor in rat hippocampus is coupled with an increase in caspase‐3 activation , 2002, The European journal of neuroscience.
[11] P. Mcgeer,et al. Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. , 2010, Journal of Alzheimer's disease : JAD.
[12] C. Gottfried,et al. Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology , 2000, FEBS letters.
[13] R. Schliebs,et al. Induction of cytokines in glial cells surrounding cortical β-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology , 2000, International Journal of Developmental Neuroscience.
[14] W. Noble,et al. Transgenic mouse models of tauopathy in drug discovery. , 2010, CNS & neurological disorders drug targets.
[15] M. Mullan,et al. p35/Cdk5 pathway mediates soluble amyloid‐β peptide‐induced tau phosphorylation in vitro , 2002, Journal of neuroscience research.
[16] Kit-Yi Leung,et al. Novel Phosphorylation Sites in Tau from Alzheimer Brain Support a Role for Casein Kinase 1 in Disease Pathogenesis* , 2007, Journal of Biological Chemistry.
[17] J. Trojanowski,et al. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.
[18] B. Hyman,et al. Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer’s disease , 2000, Journal of Neuroimmunology.
[19] S. Hickman,et al. Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice , 2008, The Journal of Neuroscience.
[20] Tony Wyss-Coray,et al. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.
[21] B. Sacchetti,et al. Astrocyte modulation of in vitro β‐amyloid neurotoxicity , 2004, Glia.
[22] R. Ransohoff,et al. Regulation of Tau Pathology by the Microglial Fractalkine Receptor , 2010, Neuron.
[23] M. Mattson,et al. Amyloid β-peptide induces apoptosis-related events in synapses and dendrites , 1998, Brain Research.
[24] D. Wallach,et al. Cell death induction by TNF: a matter of self control. , 1997, Trends in biochemical sciences.
[25] A. Nimmerjahn. Astrocytes going live: advances and challenges , 2009, The Journal of physiology.
[26] K. Pahan,et al. Fibrillar Amyloid-β-Activated Human Astroglia Kill Primary Human Neurons via Neutral Sphingomyelinase: Implications for Alzheimer's Disease , 2010, The Journal of Neuroscience.
[27] R. Swanson,et al. Astrocytes protect neurons from nitric oxide toxicity by a glutathione‐dependent mechanism , 2001, Journal of neurochemistry.
[28] R. Berry,et al. Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Julien,et al. Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease , 2006, Neuron.
[30] M. Mattson,et al. Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. , 1998, Brain research.
[31] A. Verkhratsky,et al. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease , 2010, Glia.
[32] P. Mcgeer,et al. Inflammation in transgenic mouse models of neurodegenerative disorders. , 2010, Biochimica et biophysica acta.
[33] C. Cotman,et al. Inflammatory changes parallel the early stages of Alzheimer disease , 2007, Neurobiology of Aging.
[34] W. Noble,et al. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. , 2009, Trends in molecular medicine.
[35] J. Cho,et al. Glycogen Synthase Kinase 3 (cid:1) Induces Caspase-cleaved Tau Aggregation in Situ * , 2022 .
[36] Hymie Anisman,et al. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. , 2009, Journal of psychiatry & neuroscience : JPN.
[37] Gilles Bonvento,et al. Targeted Activation of Astrocytes: A Potential Neuroprotective Strategy , 2008, Molecular Neurobiology.
[38] R. Rissman,et al. Caspase-mediated degeneration in Alzheimer's disease. , 2004, The American journal of pathology.
[39] J. Cooper,et al. Anti-Inflammatory Impact of Minocycline in a Mouse Model of Tauopathy , 2010, Front. Psychiatry.
[40] W. Noble,et al. Kinase activities increase during the development of tauopathy in htau mice , 2007, Journal of neurochemistry.
[41] C. Cotman,et al. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. , 2004, The Journal of clinical investigation.
[42] L. V. Van Eldik,et al. Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation. , 1998, Journal of neurochemistry.
[43] L. Buée,et al. P1–062: Alzheimer's disease–like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits , 2006, The American journal of pathology.
[44] W. Bowers,et al. Interferon-{gamma} differentially affects Alzheimer's disease pathologies and induces neurogenesis in triple transgenic-AD mice. , 2009, The American journal of pathology.
[45] F. LaFerla,et al. Reductions in amyloid-beta-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation. , 2010, Journal of Alzheimer's disease : JAD.